Pay in 4 interest-free payments of $5.03 Learn more
Ships within 48 hours · Estimated delivery Jul 31 - Aug 5
That is nearly one-third of body weight, among the highest ever recorded for any anti-obesity medication
(2016) 5:e18640
Knock-off versions of Eli Lilly's retatrutide, hailed as a potential 'new Ozempic', are being sold directly to US consumers Eli Lilly sparked enthusiasm about the future of retatrutide when it announced in June that Phase 2 trial results showed the drug led to an average weight loss of up to 24% over 48 weeks Eli Lilly sparked enthusiasm about the future of retatrutide when it announced in June that Phase 2 trial results showed the drug led to an average weight loss of up to 24% over 48 weeks
Mechanisms of action and therapeutic application of glucagon-like peptide-1
US$ 26.77
US$ 24.84
US$ 21.87
